Biological
Red Blood Cells (Transfusion)
Red Blood Cells (Transfusion) is a biological therapy with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown125%
completed250%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
ABC - A Post Intensive Care Anaemia Management Trial
NCT04591574
completednot_applicable
HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
NCT03260478
completedphase_2
Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients
NCT00566709
unknownnot_applicable
Restrictive Versus Liberal Red Cell Transfusion Strategy in Orthopedic-Oncology Patients Undergoing Surgery - a Randomized Controlled Study
NCT01491308
Clinical Trials (4)
Showing 4 of 4 trials
NCT04591574Not Applicable
ABC - A Post Intensive Care Anaemia Management Trial
NCT03260478Not Applicable
HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
NCT00566709Phase 2
Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients
NCT01491308Not Applicable
Restrictive Versus Liberal Red Cell Transfusion Strategy in Orthopedic-Oncology Patients Undergoing Surgery - a Randomized Controlled Study
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4